November 22, 2017 10:39 PM ET

Biotechnology

Company Overview of Genzyme Corporation

Key Executives for Genzyme Corporation

NameBoard RelationshipsTitleAge
Marc Esteva No RelationshipsChief Financial Officer--
Scott A. Canute MBA77 RelationshipsExecutive Vice President and President of Manufacturing & Corporate Operations56
John G. Schulte No RelationshipsPresident of Surgical Products68
William Aitchison No RelationshipsHead of Global Industrial Operations--
Mark Barrett No RelationshipsGlobal Head of Strategy & Business Development and Vice President--
View More Key Executives

Genzyme Corporation Board Members*

NameBoard RelationshipsPrimary CompanyAge
Charles Leland Cooney Ph.D. 178 RelationshipsMitra Biotech Pvt Ltd73
Cornelius McGillicuddy III 22 RelationshipsH. Lee Moffitt Cancer Center & Research Institute, Inc.76
Gail Koziara Boudreaux 35 RelationshipsZimmer Biomet Holdings, Inc.56
Robert J. Bertolini 54 RelationshipsIdorsia Ltd56
Robert J. Carpenter 86 RelationshipsREC, Inc.71
View All Board Members

Genzyme Corporation Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Robert J. Bertolini54 Relationships6 Executives
Compensation Committee Ph.D.Charles Leland Cooney178 Relationships5 Executives
Nominating Committee IIICornelius McGillicuddy22 Relationships4 Executives
Corporate Governance Committee IIICornelius McGillicuddy22 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
386.6K
Bonus
240.2K
Total Short Term Compensation
483.0K
Total Value of Options
17.7M
Compensation as of Fiscal Year
Genzyme Corporation CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Pieris Pharmaceuticals, Inc. Announces Executive Changes
November 21, 2017 1:40 PM ET
Riot Blockchain, Inc. Appoints Frank M. Bishop to Advisory Board
November 21, 2017 1:30 PM ET
Biogen Appoints Jeffrey D. Capello as Executive Vice President and Chief Financial Officer, Effective as of December 11, 2017
November 21, 2017 12:30 PM ET
Joseph Shan Resigns as Vice President, Clinical & Regulatory Affairs of Peregrine Pharmaceuticals, Inc
November 20, 2017 9:46 PM ET
Enanta Pharmaceuticals, Inc. Appoints Bryan Goodwin as Vice President of Biology
November 20, 2017 9:01 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Genzyme Corporation, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.